Massimo Lopez

3.0k citations
59 papers · 2.2k · 1 hit paper · h-index 21

Impact in

  • Oncology top 2%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Neutropenia and Cancer Infections
    • Cancer Genomics and Diagnostics

Papers in

    • Cancer Treatment and Pharmacology 17
    • Colorectal Cancer Treatments and Studies 6
    • HER2/EGFR in Cancer Research 5
    • Sarcoma Diagnosis and Treatment 5
    • Gastric Cancer Management and Outcomes 4

Massimo Lopez

56 papers receiving 2.1k citations

Massimo Lopez's Hit Papers

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale 2005 · 591 citations
5910+7+14Years since publication100200300400500

Peers

Massimo Lopez
Comparison fields: 5 of 89
  • Oncology 1.3k
  • Cancer Research 326
  • Hepatology 165
  • Pulmonary and Respiratory Medicine 366
  • Pathology and Forensic Medicine 146
Replace Nobuyuki Mizunuma with:
Nobuyuki Mizunuma Japan
M Francoual France
Per‐Ebbe Jönsson Sweden
D. Amoroso Italy
Carles Pericay Spain
G Brufman Israel
Yutaka Ogata Japan
D. Depisch Austria
Giovanna Masci Italy
Veronica Lonati Italy
Massimo Lopez relative to Nobuyuki Mizunuma Japan Nobuyuki Mizunuma's profile →
Citations per field
00.5×1.5×
Nobuyuki Mizunuma · 1×
Citations per year

Countries citing papers authored by Massimo Lopez

Since Specialization
Citations

This map shows the geographic impact of Massimo Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Lopez more than expected).

Fields of papers citing papers by Massimo Lopez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Lopez. The network helps show where Massimo Lopez may publish in the future.

Co-authors

The 25 scholars most cited alongside Massimo Lopez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Massimo Lopez Line = papers co-authored together Massimo Lopez links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale
Hit paper breakdown →
2005591
2
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
2002323
3 2002231
4 2006150
5 200574
6 200365
7 200148
8 200841
9
Molecular staging of non-small cell lung cancer according to K-ras genotypes.
199641
10 200938
11 198934
12 200233
13 200627
14 198626
15 199325
16 198625
17 200423
18 199722
19 200221
20 201120

About Massimo Lopez

Massimo Lopez is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health, having authored 59 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (17 papers), Breast Cancer Treatment Studies (8 papers), Colorectal Cancer Treatments and Studies (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers), HER2/EGFR in Cancer Research (5 papers), Male Breast Health Studies (5 papers), Sarcoma Diagnosis and Treatment (5 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (326 citations), Hepatology (165 citations), Pulmonary and Respiratory Medicine (366 citations) and Pathology and Forensic Medicine (146 citations). Massimo Lopez has collaborated with scholars based in Italy, United States and Malaysia. Frequent co-authors include Vittorio Gebbia, Giuseppe Colucci, Francesco Giuliani, Evaristo Maiello, Luigi Di Lauro, S. Cigolari, Generoso Uomo, Antonio Testa, Maria Biglietto and Antonio Giordano. Their work appears in journals such as Oncology, Journal of Clinical Oncology, Cancer, Investigational New Drugs and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact